Down's syndrome

From The School of Biomedical Sciences Wiki
Revision as of 19:55, 1 December 2015 by 150351065 (Talk | contribs)
Jump to: navigation, search

Down's syndome is disorder caused by having an extra chromosome on chromosome 21 (referred to as trisomy 21), giving a total of 47 chromosomes instead of the normal 46 in humans.This extra chromosome copy disrupts the normal course of brain and body development, thus affecting both physical development and intellectual ability. Although individuals with Down's syndrome behave and look similar, their intellectual capability varies from mild to moderately low. As sufferers age (often about the age of 50), they may often experience a progressive decline in cognitive function, which can result in an increased risk of Alzheimer's, a neurodegenerative disease that causes dementia: a gradual loss of memory, motor skills, and judgement.[1] 



There are three main types of Down's syndrome.

Trisomy 21

An error during gamete formation results in a failure of the chromosomal pair on chromosome 21 to separately properly, which results in an embryo with three copies of chromosome 21. This is known as non-disjunction. Most cases of Down's syndrome are a result of a random chromosomal defect during the formation of reproductive cells, especially egg cells. As the embryo develops, the extra chromosome is replicated in every cell of the body. This is the most common form, and accounts for about 95% of cases.[2] [3]

Mosaic trisomy 21

Mosaic refers to mixed or a combination. Most cells in the body have 47 chromosomes, whereas some of the cells have 46 chromsomes. Like trisomy 21, this isn't inherited; instead it is caused by random events that occur during cell division in early foetal development. This is the least common form and accounts for about 1% of cases.

Translocation trisomy 21

Part of chromosome 21 is in the cell, which becomes attached to another chromosome during gametic cells formation or during early foetal development. This is transferred to other cells as it divides. In some cases, parents unaffected by Down's syndrome may have translocation trisomy 21, which can be inherited by their offspring.


To date, the cause of the extra chromosome is still unknown, Increasing maternal age (especially pregnant women aged 35 or over) is a contributory factor towards a higher risk of a baby having Down's syndrome with trisomy 21 or mosaicism. There is no conclusive scientific research to suggest that environmental factors or parental activities before or during preganancy are the causes. 



Young children are more susceptible to developmental delay. This may be a consequence of poor muscle tone, which impacts the ability to stand, balance, and sit normally, so they may reach these milestones slower than other children.

Intellectual and behavioural

Screening and diagnosis

Before a clinical diagnosis is made, prenatal screening tests are carried out to predict the probability of the foetus having Down's syndrome. Conversely, diagnostic tests are more accurate in determining whether or not the foetus will have Down's syndrome. 


Blood (serum screening) tests - measures amount of substances in maternal blood, and along with the mother's age, doctors use this information to estimate the probability of the baby developing Down's syndrome. 

Ultrasound - often used in conjuction with blood test, this creates a picture of the baby. Doctors observe any fluid behind the baby's neck as this can indicate genetic defects. 

Prenatal diagnosis

Chorionic villus sampling - obtain a small sample of material from the placenta (chorionic villus) and test for abnormalities. 

Amniocentisis - examines amniotic fluid (fluid sac surrounding the baby), and test it for protein levels.

Percutaneous umbilical blood sampling - examines blood from the umbilical cord, which is then tested for the extra chromosome. This is the most accurate method, and can be used to confirm CVS and amniocentisis, however, this can only be carried out in the later stages of pregnancy. 

Diagnosis at birth

At birth, doctors observe whether or not the newborn has any of the typical characteristics such as: weak muscle tone, upward slanting eyes and flattened facial profiles. However, these traits may also be present in those without Down's syndrome. Therefore it is important to carry out further analysis. 

Karyotope analysis - doctors obtain a blood sample from the newborn and examine karyotypes to detect any chromosomal abnormalities. 


There is not a universal, standardised treatment for those affected by Down's syndrome. However, there are a range of treatments provided according to the individual's physical and mental requirements, which includes but isn't limited to: early intervention programmes, and also speech, physical and occupational therapy. Those with Down's syndrome are more susceptible to other conditions and disorders so it is essential that healthcare professionals provide them with regular medical support. 


  1. Genetics Home Reference. Down syndrome. Available at: (Last accessed 01/12/15)
  2. NDSS. (n.d.). What causes Down syndrome? Retrieved June 11, 2012, from (Last accessed 01/12/15)
  3. Genetic and Rare Diseases Information Center (GARD). (2012). Down syndrome. Retrieved June 11, 2012, from

Personal tools